154 related articles for article (PubMed ID: 7002420)
1. Clinical pharmacokinetics of metoprolol.
Regårdh CG; Johnsson G
Clin Pharmacokinet; 1980; 5(6):557-69. PubMed ID: 7002420
[No Abstract] [Full Text] [Related]
2. The pharmacokinetics of metoprolol and its metabolites in dialysis patients.
Seiler KU; Schuster KJ; Meyer GJ; Niedermayer W; Wassermann O
Clin Pharmacokinet; 1980; 5(2):192-8. PubMed ID: 7363534
[TBL] [Abstract][Full Text] [Related]
3. The effect of pretreatment with cimetidine on the bioavailability and disposition of atenolol and metoprolol.
Houtzagers JJ; Streurman O; Regårdh CG
Br J Clin Pharmacol; 1982 Jul; 14(1):67-72. PubMed ID: 6125199
[TBL] [Abstract][Full Text] [Related]
4. A pharmacokinetic comparison between different slow-release formulations of metoprolol (Lopresor SR and Betaloc SA).
Browning RC; John VA; Till RJ; Theobald W
Br J Clin Pharmacol; 1981 Oct; 12(4):600-2. PubMed ID: 7295497
[No Abstract] [Full Text] [Related]
5. Comparative pharmacokinetic profiles of metoprolol and chlorthalidone administered alone or in combination to healthy volunteers.
Godbillon J; Gerardin A; John VA; Theobald W
Eur J Clin Pharmacol; 1983; 24(5):655-60. PubMed ID: 6873146
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.
Regårdh CG; Jordö L; Ervik M; Lundborg P; Olsson R; Rönn O
Clin Pharmacokinet; 1981; 6(5):375-88. PubMed ID: 7333059
[TBL] [Abstract][Full Text] [Related]
7. Influence of inflammatory disease on the clinical pharmacokinetics of atenolol and metoprolol.
Kirch W; Spahn H; Ohnhaus EE; Köhler H; Heinz U; Mutschler E
Biopharm Drug Dispos; 1983; 4(1):73-81. PubMed ID: 6839004
[TBL] [Abstract][Full Text] [Related]
8. Metoprolol kinetics and dose response in hypertensive patients.
Myers MG; Thiessen JJ
Clin Pharmacol Ther; 1980 Jun; 27(6):756-62. PubMed ID: 7379442
[TBL] [Abstract][Full Text] [Related]
9. Effect of rifampicin on metoprolol and antipyrine kinetics.
Bennett PN; John VA; Whitmarsh VB
Br J Clin Pharmacol; 1982 Mar; 13(3):387-91. PubMed ID: 7059439
[TBL] [Abstract][Full Text] [Related]
10. The effect of impaired renal function on the plasma concentration and urinary excretion of metoprolol metabolites.
Hoffmann KJ; Regårdh CG; Aurell M; Ervik M; Jordö L
Clin Pharmacokinet; 1980; 5(2):181-91. PubMed ID: 7363533
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability and disposition of metoprolol and hydrochlorothiazide combined in one tablet and of separate doses of hydrochlorothiazide.
Jordö L; Johnsson G; Lundborg P; Persson BA; Regärdh CG; Rönn O
Br J Clin Pharmacol; 1979 Jun; 7(6):563-7. PubMed ID: 465277
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of metoprolol and its metabolite alpha-OH-metoprolol in healthy, non-smoking, elderly individuals.
Regårdh CG; Landahl S; Larsson M; Lundborg P; Steen B; Hoffmann KJ; Lagerström PO
Eur J Clin Pharmacol; 1983; 24(2):221-6. PubMed ID: 6840171
[TBL] [Abstract][Full Text] [Related]
13. Increased oral clearance of metoprolol in pregnancy.
Högstedt S; Lindberg B; Rane A
Eur J Clin Pharmacol; 1983; 24(2):217-20. PubMed ID: 6840170
[TBL] [Abstract][Full Text] [Related]
14. Investigation of drug absorption from the gastrointestinal tract of man. IV. Influence of food and digestive secretions on metoprolol jejunal absorption.
Evard D; Vidon N; Godbillon J; Bovet M; Duval M; Schoeller JP; Bernier JJ; Hirtz J
Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):119S-125S. PubMed ID: 4005113
[TBL] [Abstract][Full Text] [Related]
15. The effect of age on the pharmacokinetics of metoprolol and its metabolites.
Quarterman CP; Kendall MJ; Jack DB
Br J Clin Pharmacol; 1981 Mar; 11(3):287-94. PubMed ID: 7213530
[TBL] [Abstract][Full Text] [Related]
16. Disposition of metoprolol in the newborn.
Lundborg P; Agren G; Ervik M; Lindeberg S; Sandstrom B
Br J Clin Pharmacol; 1981 Oct; 12(4):598-600. PubMed ID: 7295496
[No Abstract] [Full Text] [Related]
17. Accumulation of atenolol and metoprolol in human breast milk.
Liedholm H; Melander A; Bitzén PO; Helm G; Lönnerholm G; Mattiasson I; Nilsson B; Wåhlin-Boll E
Eur J Clin Pharmacol; 1981; 20(3):229-31. PubMed ID: 7286041
[No Abstract] [Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function.
Jordö L; Attman PO; Aurell M; Johansson L; Johnsson G; Regårdh CG
Clin Pharmacokinet; 1980; 5(2):169-80. PubMed ID: 6102500
[TBL] [Abstract][Full Text] [Related]
19. Oxidation phenotype--a major determinant of metoprolol metabolism and response.
Lennard MS; Silas JH; Freestone S; Ramsay LE; Tucker GT; Woods HF
N Engl J Med; 1982 Dec; 307(25):1558-60. PubMed ID: 7144837
[No Abstract] [Full Text] [Related]
20. Determination of metoprolol metabolites in plasma and urine by electron-capture gas--liquid chromatography.
Quarterman CP; Kendall MJ; Jack DB
J Chromatogr; 1980 Jul; 183(1):92-8. PubMed ID: 7400270
[No Abstract] [Full Text] [Related]
[Next] [New Search]
